Identification of key candidate genes and pathways revealing the protective effect of liraglutide on diabetic cardiac muscle by integrated bioinformatics analysis

BACKGROUND: Diabetes mellitus is becoming a significant health problem with the International Diabetes Federation (IDF) expecting a startling 642 million diabetes patients by 2040. Liraglutide, a glucagon-like peptide-1 (GLP-1) analog, is reported to protect against diabetic cardiomyopathy by bindin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Ying, Yan, Shi, Li, Guo-Yan, Wang, Min-Nan, Leng, Lei, Li, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154457/
https://www.ncbi.nlm.nih.gov/pubmed/32309328
http://dx.doi.org/10.21037/atm.2020.01.94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154457/
https://www.ncbi.nlm.nih.gov/pubmed/32309328
http://dx.doi.org/10.21037/atm.2020.01.94

Ejemplares similares